The Polish Anti-Doping Laboratory (PLAD) is a state legal entity, operating under the regulations of The Anti-Doping Law.
Supervision of the Laboratory is performed by the minister responsible for health matters.
The Minister responsible for health matters shall, by means of an ordinance, grant the statute of the Laboratory, in which he determines its internal organization and the mode of work of its authorities, with a view to the efficient performance of the Laboratory's tasks.
The main task of the Laboratory is to analyze anti-doping samples of urine and/or blood in order to identify prohibited substances that are on the World Anti-Doping Agency (WADA) list of prohibited substances.
The Laboratory does not participate in the process of determining the responsibility of athletes, does not determine the origin of substances and does not manage the results of tests.
The laboratory does not possess personal data of athletes.
The Laboratory (PLAD) cooperates with POLADA, while it is a completely separate entity and performs completely different tasks. The Polish Anti-Doping Laboratory (PLAD) should not be identified with the Polish Anti-Doping Agency (POLADA), as they are separate and independent entities.
The Polish Anti-Doping Laboratory (previously the Department of the Anti-Doping Research of Sport Institute -PIB) has held the World Anti-Doping Agency WADA accreditation since November 2004, and is amongst 30 of such laboratories around the world. Whereas since March 10 1997, it has been accredited by the Polish Center for Accreditation (PCA).
The Polish Anti-Doping Laboratory operates both in Poland and internationally. It carries out a wide-ranging cooperation with organizations and entities as part of operational activities, which include:
- analyzes for WADA signatories (including the Polish Anti-Doping Agency POLADA);
- analyzes for organizations / entities that are not WADA signatories (including the Polish Equestrian Association PZJ);
- clinical, toxicological and forensic analyzes (including the police, prosecutor's office, hospitals).
In addition to the analysis of anti-doping samples, the Laboratory supports the Athlete Passport Management Units (APMU) operating by the Laboratory.
Contact
Organization
The Laboratory Council II
On January 1, 2023, the Minister of Health appointed members of the 2nd term of office of the Council of the Polish Anti-Doping Laboratory. The Council consists of:
As representatives indicated by the Minister of Health:
Prof. Marek Mędraś MD, Ph.D - Chairman of the Council
Specialist in Internal Medicine, Specialist Endocrinologist-Andrologist. Employment: research and didactic employee of the Medical University in the Department of Endocrinology, Diabetology and Isotope Therapy in Wroclaw, at the position of full professor. Since 1996, he has been employed as an associate professor at the Academy of Physical Education in Wroclaw.Member of the Polish Society of Endocrinology and the Polish Society of Andrology.Scientific research: in the field of sports medicine including the problem of androgen-anabolic doping (influence on the function of the male gonads ), some aspects of anti-doping control or issues concerning the mineral density of the skeletal system in people practicing various sports.
Prof. Natalia Pawlas MD, Ph.D - Deputy Chairman of the Council
Specialist in intensive care (2022), clinical toxicology (2017) and occupational medicine (2013). She graduated in 2003 from the Faculty of Medicine in Katowice, then the Silesian Medical Academy. She also received her doctoral degree in medicine from the aforementioned Faculty in 2008 on the basis of her dissertation "Effect of arachidonic acid on rat cerebral cortex neurons under the conditions of an in vitro ischemia model," and received her postdoctoral degree in medical science in the discipline of medicine, specialty: pharmacology and toxicology, in 2016. at the Faculty of Medicine with the Division of Medicine and Dentistry in Zabrze SUM in Katowice, on the basis of a series of publications under the common title "Environmental exposure of children to lead - health effects and their determinants."
From 2007 to 2019, she worked at the Institute of Occupational Medicine and Environmental Health in Sosnowiec (Department of Chemical Hazards and Genetic Toxicology, where she served as head of the Genetic Toxicology Laboratory), as well as at the Regional Acute Poisoning Center with the Clinical Toxicology Department.
Since October 2016, he has been Head of the Department of Pharmacology of the Faculty of Medical Sciences in Zabrze SUM in Katowice, currently at the position of SUM professor. Since June 2019, he has also worked in the Department of Toxicology at the St. Barbara Regional Specialized Hospital No. 5 in Sosnowiec.
In addition, she is a Provincial Consultant in clinical toxicology and a member of the Scientific Council of the Institute of Occupational Medicine in Lodz.
She was appointed to the Committee of Physiological and Pharmacological Sciences of the Polish Academy of Sciences for the 2020-2023 term. She gives lectures on toxicology as part of CMKP specialization courses. She is a member of, among others, the Polish Society of Pharmacology (currently Chair of the Board of the Silesian Branch), the Polish Society of Toxicology, and the International Commission on Occupational Health (currently Chair of the Scientific Committee on Toxicology of Metals).
Marta Nowacka-Chmielewska, MD, PhD
Doctor of medicine and health sciences with a specialty in neuropharmacology. Graduate in biotechnology at the Silesian Medical University in Katowice and postgraduate studies in molecular biology at the Jagiellonian University in Krakow.
Professor in the Department of Physiotherapy in Musculoskeletal Dysfunctions and Sports Medicine and Head of the Molecular Research Laboratory at the Institute of Physiotherapy and Health Sciences at the Academy of Physical Education in Katowice.Specialist at the Center for Experimental Medicine of the Silesian Medical University in Katowice.
Manager and co-principal investigator of research projects addressing the effects of chronic stress, physical activity, training and diet on central nervous system function in animal models. Author of scientific publications and conference reports in the field of neuroscience.
She is a member of the Polish Society for Nervous System Research, as well as the Federation of European Neuroscience Societies (FENS).
Privately, first and foremost a mother with a passion for travel, literature and sports.
Ewa Sobiech, Msc
Chief specialist at the Ministry of Health.
Postgraduate studies in Medical Law, Bioethics and Sociology of Medicine at the University of Warsaw. Postgraduate studies in Audit and Internal Control in Administration and Economy.
Qualification as an inspector of Personal Data Protection.
Representative indicated by the Minister of Education and Science:
Prof. Janusz Solski Ph.D
Specialist in clinical analytics, head of the Department of Laboratory Diagnostics at the Medical University of Lublin, former Dean of the Faculty of Pharmacy. Long-time Regional and Provincial Consultant in the field of laboratory diagnostics. Member of the State Examination Commission in the field of Medical Laboratory Diagnostics, member of the Polish Accreditation Commission.
The Laboratory Council I
On January 1, 2019, the Minister of Sport and Tourism appointed members of the first compostion of the Council of the Polish Anti-Doping Laboratory. The Council consists of:
As representatives indicated by the Minister of Sport and Tourism:
- Prof. Marek Mędraś MD, Ph.D
- Natalia Pawlas MD Ph.D
- Marta Nowacka-Chmielewska, MD, PhD
Representative indicated by other departments:
- MSc Ewa Sobiech
- Prof. Tadeusz Bednarczyk MD, Ph.D, Eng.
Legal acts
 |
 |
 |
|
USTAWA z dnia 21 kwietnia 2017 r. o zwalczaniu dopingu w sporcie |
USTAWA z dnia 6 grudnia 2018 r. o zmianie ustawy o zwalczaniu dopingu w sporcie |
Rozporządzenie Ministra Sportu i Turystyki z dnia 22 stycznia 2019 r. w sprawie nadania statutu Polskiemu Laboratorium Antydopingowemu |
 |
 |
 |
|
USTAWA z dnia 27 listopada 2020 r. o zmianie ustawy o zwalczaniu dopingu w sporcie |
USTAWA z dnia 2 grudnia 2021 r. o zmianie ustawy o zwalczaniu dopingu w sporcie |
USTAWA z dnia 2 grudnia 2021 r. o zmianie ustawy o zwalczaniu dopingu w sporcie - tekst ujednolicony |
 |
 |
|
| Rozporządzenie Prezesa Rady Ministrów z dnia 16 marca 2022 r. w sprawie przeniesienia planowanych wydatków budżetowych, w tym wynagrodzeń, określonych w ustawie budżetowej na rok 2022 | ROZPORZĄDZENIE MINISTRA ZDROWIA z dnia 6 marca 2019 r. w sprawie wykazu podmiotów uprawnionych do przeprowadzania badań mających na celu ustalenie, czy dany produkt jest środkiem zastępczym |
